Biotech

All Articles

8 months after a $213M fundraise, gene editor Volume creates reduces

.After increasing $213 thousand in 2023-- one of the year's largest private biotech rounds-- Volume ...

BioMarin constructs exec staff along with biotech veterinarians-- Chutes &amp Ladders

.Welcome to this week's Chutes &amp Ladders, our summary of significant leadership hirings, shooting...

Biopharma Q2 VC struck highest level due to the fact that '22, while M&ampA reduced

.Equity capital funding into biopharma cheered $9.2 billion throughout 215 deals in the second quart...

Bicara, Zenas look for IPOs to drive late-phase assets toward market

.Bicara Rehabs and also Zenas Biopharma have actually delivered new incentive to the IPO market alon...

Genentech to shut cancer immunology analysis division

.Genentech will shut its own cancer cells immunology investigation division, as well as unit head an...

Kezar goes down strong growth but to confirm its really worth in phase 1 trial

.Kezar Lifestyle Sciences is falling its dim period 1 solid cyst drug as the biotech goes all-in on ...

Acelyrin goes down izokibep, dismisses 3rd of personnel

.Despite izokibep sustaining its newfound winning touch in the center, Acelyrin is no more concentra...

Rivus' period 2 obesity-related heart failure trial reaches endpoint

.Rivus Pharmaceuticals has plumped up the potential customers of its own fat-busting, muscle-sparing...

Ovid stops preclinical job, IV program after soticlestat stop working

.Ovid Therapy presently showed final month that it was actually trimming back its own headcount as t...

Eli Lilly opens $700M nucleic acid R&ampD center in Boston Port

.Eli Lilly has actually opened a $700 thousand R&ampD facility in the Boston ma Port, boosting its R...